The Global Superficial Punctate Keratitis Treatment Industry is on a trajectory of substantial growth, with a projected valuation of US$ 5.3 billion in 2023 and an anticipated compound annual growth rate (CAGR) of 6.33% until 2033, according to a recent report by Future Market Insights.
The rise in the prevalence of infectious diseases has emerged as a significant driver for the superficial punctate keratitis treatment market. The disease tends to become more extensive with the increase in temperature, particularly affecting tropical regions. Consequently, the global temperature rise is identified as a crucial factor influencing the incidence of keratitis, thereby propelling the market forward.
A noteworthy determinant of the global demand for keratitis treatment is the escalating medical spending worldwide. Despite a few advancements limiting sales growth, the keratitis treatment market presents a significant opportunity for the detection of coronary eye diseases with substantial investments expected in the coming years. However, the spread of this disease is also attributed to poor sanitary conditions prevalent in developing nations.
Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-17066
The disease is transmitted as a result of poor sanitary conditions in developing nations. Although, wearing contact lenses while swimming is another aspect ramping up the contamination of the eye, thus this is also contributing to the contribution of the keratitis treatment.
Recently, intervention in surgery may also be an option for patients with refractory superficial punctate keratitis, not responding to medical treatment, and severe fungal infections. The penetration of keratoplasty is considered to be the most common surgical intervention for serious fungal keratitis and cases with perforation or impending perforation. Modern advances have added more options like targeting the drug delivery at the site of infection in the form of intrastromal injections, collagen cross-linking, and rose Bengal-aided photodynamic therapy.
North America is said to have the dominant share due to the rapid usage of modernization and contact lens, but individuals living in developing countries, specifically in remote regions are said to be more affected because of the lack of access to healthcare providers because of low revenues.
Key Takeaways from the Global Superficial Punctate Keratitis Treatment Industry Study
- Around 3.7 billion people under the age of 50 have Superficial Keratitis.
- The global superficial punctate keratitis treatment market grew at a CAGR of 5.56% from 2018 to 2022
- PCR is highly sensitive, but a large variation has been observed in numerous studies between the rates of SPK detection by PCR when compared to clinical diagnosis.
- The treatment of Superficial Punctuate keratitis usually involves medicine, including eye drops or antiviral medications taken by mouth
Request Your Customized Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-17066
Competitive Landscape
Some of the prominent players in the Global Superficial Punctate Keratitis Treatment Industry are-
- Dompé Farmaceutici
- Allergan
- Bausch Health Companies Inc.
- CONTACARE
- OHTO Pharmaceutical Co., Ltd.
- Pfizer, Inc.
- Neuroptika
- Santen Pharmaceutical Co., Ltd.
- Johnson & Johnson
- Grand Pharma Co., Ltd.
- Zhejiang CONBA Pharmaceutical Co., Ltd.
Some of the important developments of the key players in the market are:
- In November 2020, Pfizer Inc. completed the transaction to spin off its Upjohn Business and combine it with Mylan N.V. to form Viatris Inc.
- In September 2020, Bausch Health Companies Inc. agreed to acquire an option to purchase all ophthalmology assets of Allegro Ophthalmics.
- In August 2016, Allergen plc agreed to acquire ForSight VISIONS, a privately held, clinical-stage biotechnology company focused on eye care, for a US$ 95 million upfront payment.
More Valuable Insights Available
Future Market Insights offers an unbiased analysis of the global neurotrophic keratitis treatment market, providing historical data for 2018 to 2022 and forecast statistics from 2023 to 2033.
To understand opportunities in neurotrophic keratitis treatment, the market is segmented based on treatment type by Countries (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa), by Drugs class (Amphotericin B, Griseofulvin, Voriconazole), by Route of Administration (oral, topical), and by Distribution Channel (hospital pharmacies, retail pharmacies, and online pharmacies)
Click Here To Buy Your Full Report
https://www.futuremarketinsights.com/checkout/17066
Key Segments Profiled in the Global Superficial Punctate Keratitis Treatment Industry Report
By Drug Class:
- Amphotericin B
- Griseofulvin
- Voriconazole
By Route of Administration:
- Oral
- Topical
By Distribution Channel:
- Hospital pharmacies
- Retail pharmacies
- Online pharmacies
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https: www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
